MARATTO
Available for engagements
Dr Vuyisile Phehane profile photo

Dr Vuyisile Phehane

Executive Manager

Johannesburg, South AfricaLinkedIn

IN THEIR OWN WORDS

It is our responsibility to enable the commercialization of African research and to pursue the convergence of technologies for the economic and social benefit of the continent and the world.

Dr Vuyisile Phehane

On joining MARATTO™

01 · Domain expertise

What I work on

CommercialisationIntellectual Property (IP)Technology Licensing & CommercialisationLife Sciences & BiotechVenture & Investment ReadinessResearch-to-Market StrategyGo-to-Market & Growth StrategyOther

02 · About

About Vuyisile

I have over 20 years’ experience in the funding, creation, protection and commercialization of Intellectual Property in local and global territories. Across my career, I have developed a strong track record in technology commercialisation and revenue generation, including managing over R65 million in royalty income and enabling international market access for locally developed innovations. I have deployed over R1 billion in funding towards various initiatives in biotech in my career. Using my specific strengths in due diligence for investment decisions, I have successfully structured and negotiated commercial agreements, supported venture development, mediated IP ownership disputes, and contributed to building innovation ecosystems that drive both financial returns and broader socio-economic impact. I have training in Venture Capital (I am a Fellow of Dream VC, an investor-accelerator, community-driven education platform centred specifically around venture capital across Africa's start-up ecosystems. My training in Impact Investment, and the contacts developed in these specialist fields have assisted in bringing funding to innovations. I have identified best practices in technology incubator and accelerator programmes whilst on fellowship in the USA, as an Eisenhower Fellow. I have served on the boards of several start-up as well as established companies in the Life Sciences.